According to a recent study, tirzepatide and semaglutide offer long-term health benefits but are not cost-effective.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

The thyroid, a small but powerful butterfly-shaped gland at the front of the neck, plays a crucial role in regulating key ...

Briana Adesso, 31, was a very social person who would routinely go out with friends when she suddenly gained about 40 pounds ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...